First Trust Advisors LP Tyme Technologies, Inc. Transaction History

First Trust Advisors LP

  • $101 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$0.23 - $0.35 $1,006 - $1,532
-4,378 Reduced 2.67%
159,316 $45,000
Q1 2022

May 13, 2022
SELL
$0.28 - $0.68 $2,660 - $6,461
-9,502 Reduced 5.49%
163,694 $57,000
Q4 2021

Feb 08, 2022
BUY
$0.6 - $1.04 $12,840 - $22,257
21,401 Added 14.1%
173,196 $104,000
Q3 2021

Nov 15, 2021
BUY
$0.99 - $1.38 $150,277 - $209,477
151,795 New
151,795 $156,000

About TYME TECHNOLOGIES, INC.

TYME Quotes by TradingView
  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email